Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies

Annals of Oncology : Official Journal of the European Society for Medical Oncology
Matteo LambertiniLucia Del Mastro

Abstract

The role of temporary ovarian suppression with luteinizing hormone-releasing hormone agonists (LHRHa) in the prevention of chemotherapy-induced premature ovarian failure (POF) is still controversial. Our meta-analysis of randomized, controlled trials (RCTs) investigates whether the use of LHRHa during chemotherapy in premenopausal breast cancer patients reduces treatment-related POF rate, increases pregnancy rate, and impacts disease-free survival (DFS). A literature search using PubMed, Embase, and the Cochrane Library, and the proceedings of major conferences, was conducted up to 30 April 2015. Odds ratios (ORs) and 95% confidence intervals (CIs) for POF (i.e. POF by study definition, and POF defined as amenorrhea 1 year after chemotherapy completion) and for patients with pregnancy, as well hazard ratios (HRs) and 95% CI for DFS, were calculated for each trial. Pooled analysis was carried out using the fixed- and random-effects models. A total of 12 RCTs were eligible including 1231 breast cancer patients. The use of LHRHa was associated with a significant reduced risk of POF (OR 0.36, 95% CI 0.23-0.57; P < 0.001), yet with significant heterogeneity (I(2) = 47.1%, Pheterogeneity = 0.026). In eight studies reporting amenorrhe...Continue Reading

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Apr 20, 1994·Biochemical Pharmacology·K E WoodsD A Gewirtz
Jan 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S E RivkinC K Osborne
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Aug 26, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·O PaganiH J Senn
Feb 2, 2002·Journal of Health Services Research & Policy·Julian HigginsDouglas Altman
Jul 12, 2002·Statistics in Medicine·Julian P T Higgins, Simon G Thompson
Jan 29, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R ArriagadaT Tursz
Sep 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wendy R ParulekarUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Dec 14, 2005·Statistics in Medicine·Roger M HarbordJonathan A C Sterne
Feb 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leslie R Schover
Jul 23, 2009·BMJ : British Medical Journal·David MoherUNKNOWN PRISMA Group
Jun 4, 2010·The New England Journal of Medicine·Sandra M SwainNorman Wolmark
May 4, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernd GerberUNKNOWN German Breast Group Investigators
Jul 21, 2011·JAMA : the Journal of the American Medical Association·Hope S Rugo, Mitchell P Rosen
Jan 11, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pamela N MunsterSusan E Minton
Jan 25, 2012·Journal of the National Cancer Institute·Jessica Howard-AndersonAnnette L Stanton
Sep 26, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathryn J Ruddy, Ann H Partridge
Sep 29, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M WongI E Smith
Nov 22, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hatem A AzimFedro A Peccatori
Dec 25, 2012·Obstetrics and Gynecology·Eman A ElgindyAhmed M Abou-Setta
May 28, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N H TurnerL Biganzoli
May 30, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alison W LorenUNKNOWN American Society of Clinical Oncology
Jul 3, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F A PeccatoriUNKNOWN ESMO Guidelines Working Group
Feb 26, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathryn J RuddyAnn H Partridge
Apr 8, 2014·Current Breast Cancer Reports·Giuliano BedoschiKutluk Oktay
Apr 29, 2014·The Breast : Official Journal of the European Society of Mastology·Ann H PartridgeFatima Cardoso
Jun 3, 2014·The New England Journal of Medicine·Olivia PaganiUNKNOWN International Breast Cancer Study Group
Dec 17, 2014·The New England Journal of Medicine·Prudence A FrancisUNKNOWN International Breast Cancer Study Group
Mar 5, 2015·The New England Journal of Medicine·Halle C F MooreUNKNOWN POEMS/S0230 Investigators
May 6, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A S CoatesUNKNOWN Panel Members
Jun 4, 2015·The New England Journal of Medicine·Halle C F MooreKathy S Albain

❮ Previous
Next ❯

Citations

Nov 27, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Kenny Rodriguez-WallbergKutluk Oktay
Jan 6, 2016·BMC Medicine·Matteo LambertiniPaola Anserini
Dec 10, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M LambertiniL Del Mastro
Feb 1, 2017·Proceedings of the National Academy of Sciences of the United States of America·Motohiro KanoDavid Pépin
Dec 6, 2019·International Journal of Molecular Sciences·Paola ScaruffiLucia Del Mastro
Feb 14, 2018·The Oncologist·Zeev Blumenfeld
Oct 17, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matteo LambertiniLucia Del Mastro
Jul 31, 2018·Expert Review of Endocrinology & Metabolism·Yasmin L JayasingheRichard A Anderson
Apr 12, 2017·Expert Review of Anticancer Therapy·Alicia TosoniAlba A Brandes
Jun 21, 2016·Expert Opinion on Pharmacotherapy·Matteo LambertiniLucia Del Mastro
Sep 15, 2018·Obstetric Medicine·Monica Tang, Kate Webber
Jun 23, 2016·Future Oncology·Miyuki Harada, Yutaka Osuga
May 3, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Zeev Blumenfeld
Nov 9, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matteo LambertiniLucia Del Mastro
Apr 6, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kutluk OktayAlison W Loren
Feb 12, 2017·Current Treatment Options in Oncology·Matteo LambertiniEvandro de Azambuja
Mar 29, 2017·Human Reproduction Open·Richard A AndersonEvelyn E Telfer
Nov 29, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matteo LambertiniHalle C F Moore
Apr 27, 2017·Frontiers in Endocrinology·Michael von Wolff, Petra Stute
Oct 2, 2019·JMIR Research Protocols·Jean-Baptiste PretalliUNKNOWN DATOR Group
May 18, 2019·Current Oncology Reports·Nicole Christian, Mary L Gemignani
Jul 11, 2020·Clinical Medicine Insights. Oncology·Francesca ParisiMatteo Lambertini
Feb 3, 2020·Journal of Assisted Reproduction and Genetics·Mary E Hampe, Alice S Rhoton-Vlasak
Apr 13, 2017·Expert Opinion on Pharmacotherapy·Matteo LambertiniLucia Del Mastro
Aug 23, 2017·Expert Review of Hematology·Mahmoud SalamaPeter Mallmann
Oct 4, 2017·Southern Medical Journal·Cristina O'DonoghueM Catherine Lee
Oct 22, 2017·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·J C SenraR L C Tavares
Apr 6, 2018·Journal of Pediatric Hematology/oncology·Mariaclaudia MeliAndrea Di Cataldo
Nov 2, 2018·Breast Cancer Research and Treatment·Małgorzata SzostakowskaAnna Fabisiewicz
Jun 14, 2019·Clinical Medicine Insights. Reproductive Health·Taichi AkahoriJonathan L Tilly
Sep 7, 2019·Clinical Medicine Insights. Reproductive Health·Zeev Blumenfeld
Jul 7, 2018·Therapeutic Advances in Medical Oncology·Matteo B Suter, Olivia Pagani
Jul 25, 2019·Best Practice & Research. Clinical Endocrinology & Metabolism·Rashi KalraCatharyn Stern
Sep 21, 2018·American Society of Clinical Oncology Educational Book·Karen Lisa SmithHalle Moore
Jan 16, 2021·Current Oncology Reports·Zhaohui JinAllison C Rosenthal
Mar 21, 2019·Current Opinion in Oncology·Margherita CondorelliSharon L Bober

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Asian Pacific Journal of Cancer Prevention : APJCP
Quan-Bin ZhaXin-Yu Xu
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Ying-Ze ZhangYong Shen
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
Angiolo GadducciIlaria Guiggi
© 2021 Meta ULC. All rights reserved